News

The Defense Threat Reduction Agency's (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD) Program has awarded, through the Medical CBRN Defense Consortium (MCDC) requirement 22-05, "Adjuvant Activity to Vaccines Prototype," a 5-year...

There are currently more than 3,000 advanced therapies in the development pipeline globally, along with 124 approved therapies. To enable this innovation and transformation of therapeutic options, Azzur Group today announces the introduction of analytical laboratory testing services for...

AstraZeneca announced the successful completion of the acquisition of Gracell Biotechnologies Inc , a global clinical-stage biopharmaceutical company developing innovative cell therapies for the treatment of cancer and autoimmune diseases, furthering AstraZeneca’s cell therapy ambition. The acquisition enriches AstraZeneca’s growing...

Viatris Inc. a global healthcare company, announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimized Risk of Antimicrobial Resistance (AMR). The standard was facilitated by BSI...

A team led by University College Dublin (UCD) has been working on an innovative research initiative that could transform pre-eclampsia diagnosis. It is designed to support clinicians to make effective and efficient clinical diagnosis of suspected pre-eclampsia through intelligent...

In light of the upcoming International Women’s Day, PharmaLinea has announced the publication of a new clinical study, addressing one of the most pressing global health issues for women – recurring urinary tract infections (UTIs). UTIs are highly prevalent...

Big Pharma goes on to drive the demand for contract resource organizations- CROs by way of outsourcing almost 45% of research and development activities. It is well to be noted that the global biotechnology as well as pharmaceutical services...